Glycemic control and implant stabilization in type 2 diabetes mellitus

T. W. Oates, S. Dowell, M. Robinson, C. A. McMahan

Research output: Contribution to journalArticlepeer-review

118 Scopus citations


Diabetes mellitus is considered a relative contra-indication for implant therapy. However, the effect of glycemic level on implant integration in persons with diabetes remains poorly understood. The hypothesis of this research was that poor glycemic control is directly related to short-term-impairment implant stabilization. This prospective clinical study evaluated 10 non-diabetic individuals (12 implants) and 20 persons with type 2 diabetes (30 implants). Glycated hemoglobin (HbA1c) levels ranged from 4.7-12.6%. Implant stability was assessed by resonance frequency analysis over 4 months following placement. Minimum stability levels were observed 2-6 weeks following placement for all 42 implants. Persons with HbA1c ≥ 8.1% had a greater maximum decrease in stability from baseline and required a longer time for healing, as indicated by return of stability level to baseline. This study demonstrates alterations in implant stability consistent with impaired implant integration for persons with type 2 diabetes mellitus in direct relation to hyperglycemic conditions.

Original languageEnglish (US)
Pages (from-to)367-371
Number of pages5
JournalJournal of dental research
Issue number4
StatePublished - 2009


  • Diabetes mellitus
  • Hyperglycemia
  • Implant stability
  • Implants
  • Resonance frequency analysis

ASJC Scopus subject areas

  • Dentistry(all)


Dive into the research topics of 'Glycemic control and implant stabilization in type 2 diabetes mellitus'. Together they form a unique fingerprint.

Cite this